TCEL Financials 07/16/2014 12:59:16 Therapy Cells

TCEL Financials 07/16/2014 12:59:16
Therapy Cells, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue - 10 90
Cost of Revenue - - -
Gross Profit - 10 90
Operating Expenses
Research and Development - - -
Sales, General and Admin. 94 130 388
Non-Recurring Items - - 119
Other - - 1
Operating Income (95) (120) (418)
Income From Continuing Operations
Add'l Income/Expense Items - - (
Earnings Before Interest and Tax (95) (120) (425)
Interest Expense 1 6 23
Earnings Before Tax (96) (125) (449)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (96) (125) (449)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (96) (125) (449)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (96) (125) (449)